Role of Daratumumab in Cardiac AL Amyloidosis

Morie A. Gertz

doi:10.1016/j.jaccao.2022.10.003

Role of Daratumumab in Cardiac AL Amyloidosis

Hematology

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	488-490
Number of pages	3
Journal	JACC: CardioOncology
Volume	4
Issue number	4
DOIs	https://doi.org/10.1016/j.jaccao.2022.10.003
State	Published - Nov 2022

Keywords

amyloidosis
cardiomyopathy
heart failure
monoclonal antibody
treatment

ASJC Scopus subject areas

Oncology
Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.jaccao.2022.10.003

Cite this

@article{7d4d23c613954cf59305a7ce6e071c57,

title = "Role of Daratumumab in Cardiac AL Amyloidosis",

keywords = "amyloidosis, cardiomyopathy, heart failure, monoclonal antibody, treatment",

author = "Gertz, {Morie A.}",

year = "2022",

month = nov,

doi = "10.1016/j.jaccao.2022.10.003",

language = "English (US)",

volume = "4",

pages = "488--490",

journal = "JACC: CardioOncology",

issn = "2666-0873",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Role of Daratumumab in Cardiac AL Amyloidosis

AU - Gertz, Morie A.

PY - 2022/11

Y1 - 2022/11

KW - amyloidosis

KW - cardiomyopathy

KW - heart failure

KW - monoclonal antibody

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85141322653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85141322653&partnerID=8YFLogxK

U2 - 10.1016/j.jaccao.2022.10.003

DO - 10.1016/j.jaccao.2022.10.003

M3 - Editorial

AN - SCOPUS:85141322653

SN - 2666-0873

VL - 4

SP - 488

EP - 490

JO - JACC: CardioOncology

JF - JACC: CardioOncology

IS - 4

ER -

Role of Daratumumab in Cardiac AL Amyloidosis

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this